The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era
Hepatitis C virus (HCV) infection in kidney transplantation is an important issue with effects on patient and graft survival. The current standard of care involves using oral Direct Acting Antiviral drugs. Till recently, pre-transplant treatment with interferon was the only option for treatment. We...
|Main Authors:||, , , , , , , , , ,|
Wolters Kluwer Medknow Publications
|Series:||Saudi Journal of Kidney Diseases and Transplantation|